First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS G12C Solid Tumors (KRYSTAL-1).
Sai-Hong Ignatius OuPasi A JanneTiciana A LealIgor I RybkinJoshua K SabariMinal A BarveLyudmila BazhenovaMelissa Lynne JohnsonKaren L VelasteguiCornelius CilliersJames G ChristensenXiaohong YanRichard C ChaoKyriakos P PapadopoulosPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
mutation.